Journal of Southern Medical University ›› 2022, Vol. 42 ›› Issue (9): 1381-1388.doi: 10.12122/j.issn.1673-4254.2022.09.15

Previous Articles     Next Articles

Indirubin relieves inflammatory injury of chondrocytes in a mouse model of osteoarthritis

CHEN Xin, QI Xiuchun, CAO Yujing, LI Yang, LI Haoliang, WANG Qianjin, AI Jinwei   

  1. Department of Orthopedic Trauma, Henan Provincial Hospital of TCM, Zhengzhou 450002, China
  • Published:2022-09-28

Abstract: Objective To investigate the effect of indirubin for relieving joint inflammation and injury in a rat model of osteoarthritis. Methods Articular cartilage chondrocytes were isolated from adult rat knee joint and cultured in the presence of interleukin-1β (IL-1β) and 0.1, 0.5, 1.0, or 2.0 μmol/L indirubin. The cells were transfected with NPAS2 siRNA or a non-specific siRNA, and the cell proliferation and apoptosis were evaluated using tetramethylthiazole blue staining and flow cytometry. The protein expression levels of Bax, Bcl-2, ACAN, COL2A1, MMP-13 and NPAS2 were detected with Western blotting, and the levels of NO, PGE2 and TNF-α in the culture supernatant were determined with ELISA. The mRNA expression levels of NPAS2, ACAN, COL2A1 and MMP-13 were detected using fluorescence quantitative PCR. In a C57BL/6 mouse model of osteoarthritis, the effect of indirubin on BAX, Bcl-2, ACAN and MMP-13 protein expressions in the bone and joint tissues were evaluated with Western blotting. Results Treatment with 0.1 μmol/L indirubin produced no significant changes in chondrocyte proliferation, apoptosis, caspase-3 activity, or BAX and Bcl-2 protein expressions. At higher doses (0.5, 1.0 and 2.0 μmol/L), indirubin significantly promoted cell proliferation, increased Bcl- 2 protein expression, and lowered cell apoptosis rate, caspase-3 activity and Bax protein expression (P<0.05). Indirubin treatment at 0.5 μmol/L up-regulated the protein and mRNA expressions of NPAS2, ACAN and COL2A1, and down-regulated the expressions of MMP-13, NO, PGE2 and TNF-α (P<0.05). Interference of NPAS2 expression significantly attenuated the protective effect of 0.5 μmol/L indirubin against IL-1β-induced chondrocyte injury. The mouse model of osteoarthritis showed obviously increased protein levels of BAX and MMP-13 (P< 0.01) and decreased levels of Bcl-2 (P<0.05) and ACAN (P<0.01) in the knee joint, and indirubin treatment of the mouse models significantly inhibited the increase of BAX and MMP-13 protein expressions (P<0.01) and up-regulated the protein expressions of Bcl-2 and ACAN (P<0.05). Conclusion Indirubin has a protective effect on osteoarthritis tissue and alleviates inflammation and damage of osteoarthritis chondrocytes possibly through NPAS2.

Key words: indirubin; chondrocyte; NPAS2; inflammatory factors; extracellular matrix; osteoarthritis